Production (Stage)
Bicycle Therapeutics plc
BCYC
$8.05
-$0.05-0.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -203.22M | -169.03M | -166.28M | -165.37M | -168.16M |
| Total Depreciation and Amortization | 7.15M | 7.17M | 7.12M | 6.64M | 6.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.25M | 30.58M | 34.04M | 40.96M | 38.41M |
| Change in Net Operating Assets | -14.40M | -33.45M | -77.51M | -46.04M | 38.02M |
| Cash from Operations | -180.23M | -164.72M | -202.62M | -163.81M | -85.09M |
| Capital Expenditure | -1.83M | -1.24M | -918.00K | -985.00K | -842.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.83M | -1.24M | -918.00K | -985.00K | -842.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -31.95M | -31.91M | -31.86M | -- | -- |
| Issuance of Common Stock | 549.85M | 551.72M | 551.86M | 786.49M | 249.18M |
| Repurchase of Common Stock | -67.00K | -67.00K | -67.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 517.84M | 519.75M | 519.93M | 786.49M | 249.18M |
| Foreign Exchange rate Adjustments | 190.00K | -694.00K | 2.38M | -222.00K | 477.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.98M | 353.10M | 318.78M | 621.48M | 163.73M |